PTC Therapeutics, Inc. (PTCT)
63.89
-2.48
(-3.74%)
USD |
NASDAQ |
Mar 03, 10:41
PTC Therapeutics EPS Diluted (Quarterly) : -1.673 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Ardelyx, Inc. | -0.0017 |
| Spyre Therapeutics, Inc. | -0.6903 |
| Ovid Therapeutics, Inc. | -0.171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -134.96M |
| Revenue (Quarterly) | 164.68M |
| Total Expenses (Quarterly) | 299.64M |
| Enterprise Value | 3.947B |
| Gross Profit Margin (Quarterly) | 90.10% |
| Profit Margin (Quarterly) | -81.96% |
| Earnings Yield | 12.11% |
| Operating Earnings Yield | 16.14% |
| Normalized Earnings Yield | 11.97 |